| Literature DB >> 18392504 |
Larissa de Melo Alvarenga1, Mariangela Torreglosa Ruiz, Erika Cristina Pavarino-Bertelli, Maurício José Cabral Ruback, José Victor Maniglia, Maria Goloni-Bertollo.
Abstract
UNLABELLED: Head and neck cancer accounts for nearly 200.000 new cases worldwide. A mean of 13.470 new cases of cancer in the oral cavity for 100.000 inhabitants is observed in Brazil. AIM: To analyze clinical and epidemiological aspects in patients consulted in the Otorhinolaryngology and Head and Neck Surgery ward in a University hospital of Northwestern São Paulo, Brazil.Entities:
Mesh:
Year: 2008 PMID: 18392504 PMCID: PMC9450632 DOI: 10.1016/s1808-8694(15)30753-9
Source DB: PubMed Journal: Braz J Otorhinolaryngol ISSN: 1808-8686
Age distribution of head and neck cancer patients.
| Age group | Number of patients (%) |
|---|---|
| 30 a 40 | 9 (2,11) |
| 41 a 50 | 66 (15,45) |
| 51 a 60 | 121 (28,34) |
| 61 a 70 | 127 (29,75) |
| 71 a 80 | 82 (19,2) |
| 81 a 90 | 20 (4,68) |
| > 90 | 2 (0,47) |
Occupation of male head and neck cancer patients.
| Occupation of males | Number of patients (%) |
|---|---|
| Grower | 89 (24,25) |
| Bricklayer | 51 (13,9) |
| Driver | 41 (11,17) |
| Retired | 30 (8,17) |
| Shopkeeper | 16 (4,36) |
| Non-specialized services | 13 (3,55) |
| Carpenter | 11 (3) |
| Painter | 9 (2,45) |
| Guard | 9 (2,45) |
| Other | 98 (26,7) |
Occupation of female head and neck cancer patients.
| Occupation of females | Number of patients (%) |
|---|---|
| Housewife | 36 (60) |
| Retired | 9 (15) |
| Grower | 5 (8,3) |
| Other | 10 (16,7) |
Primary anatomical site in head and neck cancer patients.
| Anatomical site | Number of patients (%) |
|---|---|
| Oral cavity | 151 (35,37) |
| Larynx | 133 (31,15) |
| Oropharynx | 69 (16,15) |
| Hypopharynx | 36 (8,43) |
| Nasopharynx 8 | 8 (1,88) |
| Unknown primary site | 30 (7,02) |
Distribution of primary tumor anatomical sites according to the TNM classification (category T).
| Category | Anatomical site | Number of patients (%) |
|---|---|---|
| Oral cavity | 26 (38) | |
| Larynx | 26 (38) | |
| T1 | Oropharynx | 9 (13) |
| Hypopharynx | 4 (6) | |
| 3 (4) | ||
| Oral cavity | 39 (48) | |
| Larynx | 27 (33) | |
| T2 | Oropharynx | 11 (14) |
| Hypopharynx | 2 (2) | |
| 2 (2) | ||
| Oral cavity | 32 (30) | |
| Larynx | 38 (36) | |
| T3 | Oropharynx | 17 (16) |
| Hypopharynx | 15 (14) | |
| Nasopharynx | 2 (2) | |
| 3 (3) | ||
| Oral cavity | 39 (41) | |
| Larynx | 23 (24) | |
| T4 | Oropharynx | 21 (22) |
| Hypopharynx | 10 (11) | |
| Nasopharynx | 1 (1) | |
| Unknown primary site | 1 (1) | |
| Larynx | 2 (9,5) | |
| Tx | Nasopharynx | 1 (4,75) |
| Unknown primary site | 18 (85,75) |
Distribution of primary tumor anatomical sites according to the TNM classification (category N).
| Category | Anatomical site | Number of patients (%) |
|---|---|---|
| Oral cavity | 94 (40) | |
| Larynx | 87 (37) | |
| N0 | Oropharynx | 31 (13) |
| Hypopharynx | 15 (6) | |
| Nasopharynx | 4 (2) | |
| 2 (1) | ||
| Oral cavity | 25 (42) | |
| Larynx | 13 (22) | |
| N1 | Oropharynx | 13 (22) |
| Hypopharynx | 6 (10) | |
| 3 (5) | ||
| Oral cavity | 12 (23) | |
| Larynx | 9 (17) | |
| N2 | Oropharynx | 12 (23) |
| Hypopharynx | 7 (13) | |
| Nasopharynx | 3 (6) | |
| 9 (17) | ||
| Oral cavity | 5 (21) | |
| Larynx | 6 (25) | |
| N3 | Oropharynx | 2 (8) |
| Hypopharynx | 3 (13) | |
| 8 (33) | ||
| Nx | Larynx | 1 (33) |
| Unknown primary site | 2 (67) |
Distribution of primary tumor anatomical sites according to the TNM classification (category M).
| Category | Anatomical site | Number of patients (%) |
|---|---|---|
| Oral cavity | 120 (36) | |
| Larynx | 111 (33) | |
| Oropharynx | 54 (16) | |
| M0 | Hypopharynx | 23 (7) |
| Nasopharynx | 6 (2) | |
| 19 (6) | ||
| Oral cavity | 1 (25) | |
| M1 | Larynx | 1 (25) |
| 2 (50) | ||
| Oral cavity | 15 (43) | |
| Larynx | 4 (11) | |
| Oropharynx | 4 (11) | |
| Mx | Hypopharynx | 8 (23) |
| Nasopharynx | 1 (3) | |
| Unknown primary site | 3 (9) |
Histological differentiation of head and neck cancer patients.
| Histological differentiation | Number of patients (%) |
|---|---|
| Squamous cell carcinoma (SCC) | 413 (96,7) |
| Non-Hodgkin's lymphoma | 3 (0,69) |
| Undifferentiated carcinoma | 3 (0,69) |
| Other | 8 (1,92) |
adenocarcinoma, cystic adenoid carcinoma, clear cell carcinoma, mucoepithelioid carcinoma, poorly differentiated carcinoma.